Hyro’s Responsible AI Agent platform enables health systems to safely automate patient workflows and conversations across key channels such as call centers, websites, SMS, and mobile apps, supporting use cases like scheduling, appointments, and…
Continue Reading
What You Should Know:
– Popai Health, the Patient Conversation Intelligence company, today announced it has raised $11M in seed funding led by Team8 and NEA, alongside additional strategic investors,
– The capital intended to strengthen…
Continue Reading
The following is a guest article by Mark Noel, SVP and GM of ClaimInsight at AMPS
As health plans face escalating medical costs and increasing scrutiny over member and provider satisfaction, a critical strategic challenge…
Sanofi and QuantHealth Team up to Advance AI-Powered Digital Twins and Clinical Trials Simulations to Accelerate Drug Development
QuantHealth, a pioneer in AI-driven clinical trial simulation, announced a strategic investment from Sanofi Ventures, the venture…
Series B, Led by Lightspeed Venture Partners, Will Turbocharge Company’s Rapid Growth and Extend Their Lead Role in Using AI to Transform the Patient Experience—Eliminating the Stress Tied to Doctor’s Appointments, Lab Tests, Prescription…
Continue Reading
Catherine McDonald, deputy chief executive officer and chief strategy officer at Blackpool Teaching Hospitals NHS Foundation Trust (Credit: Blackpool Teaching Hospitals NHS FT)
Blackpool Teaching Hospitals NHS Foundation Trust is experiencing data validation issues…
Continue Reading
The Role of Emergency Departments in Healthcare Access
For millions of Americans, particularly those residing in rural and underserved communities, emergency departments (EDs) serve as the primary—and often only—gateway to timely medical care. These critical…
Q3 Financial Performance Overview
Online therapy provider Talkspace delivered impressive third-quarter results in 2025, demonstrating the company’s continued momentum in the digital mental health space. The virtual behavioral health platform reported 25% revenue growth year-over-year,…
Overview of the 340B Rebate Pilot Program
The Trump administration has officially approved eight drugmakers’ rebate plans for a controversial 340B drug discount pilot program launching January 1, 2025. This groundbreaking initiative, unveiled earlier this…
